PPMA South Zone hosted Trade Investment Officers from the Foreign Office for strategic talks on boosting export growth and tapping global market opportunities. Key leaders shared insights to amplify Pakistan’s pharma export potential.
Visit of trade investment officers (TIOs) of Foreign Office at PPMA South Zone office. Read More »
DRAP’s shift to the DRAP-PSW Gateway for export certificate applications marks a major leap forward in pharmaceutical exports.This digital move will:✅ Enhance transparency✅ Reduce processing delays✅ Promote efficient and streamlined exports
PPMA welcomes DRAP’s digital export reform Read More »
The pharmaceutical industry in Pakistan is now harnessing the power of Artificial Intelligence and advanced technologies to:✅ Accelerate drug research✅ Improve accuracy and efficiency✅ Ensure top-tier quality control
Pakistan Pharma embraces AI for smarter drug development Read More »
The inauguration ceremony of PPMA’s renovated office was graced by the online presence of Chairman Mr. Tauqeer Ul Haq, making it a truly special event.
Inauguration of PPMA’s renovated office Read More »
The 3rd CEC Meeting of 𝐏𝐏𝐌𝐀 was successfully held on 29th April 2025 at Movenpick Hotel Karachi, under the chairmanship of 𝐌𝐫. 𝐓𝐚𝐮𝐪𝐞𝐞𝐫 𝐔𝐥 𝐇𝐚𝐪, Chairman PPMA.An engaging discussion fostering collaboration and progress for the pharmaceutical industry.
3rd CEC Meeting of PPMA Successfully Held in Karachi Read More »
Pharmaceutical Companies In Pakistan ensure nationwide access to medicine. They play a critical role in the health system. These companies maintain medicine quality and support disease control. Their work impacts hospitals, clinics, and pharmacies alike. Without them, healthcare delivery becomes nearly impossible. They comply with strict global standards in operations. The Pakistan Pharmaceutical Manufacturers Association
The Role of Pharmaceutical Companies in Pakistan Read More »
The PPMA delegation met with Federal Minister for National Health Services, Regulations & Coordination, Mr. Syed Mustafa Kamal to discuss ways to strengthen collaboration between the pharmaceutical industry and the government for improved healthcare outcomes in Pakistan.
PPMA delegation meets Federal Minister NHS, R&C Read More »
The PPMA delegation met with Dr. Obaid Ullah, CEO DRAP, during a successful E-Kachehri at DRAP Headquarters, Islamabad. The session encouraged open public dialogue, with a strong commitment to transparency and accountability.
PPMA delegation meets CEO DRAP Read More »
The Special Investment Facilitation Council (SIFC) endorsed the government’s deregulation policy for pharmaceutical sector announced in February 2024, stating that the sector was undergoing a transformative shift with the deregulation of non-essential medicines. The move allowed “market competition and fair market pricing for drugs not listed on the National Essential Medicines List (NEML),” according to
Pharma sector: SIFC backs deregulation as exports surge Read More »
Pharmaceutical Production is a large and changing sector. It includes research, design, and volume production. New technologies help the industry to expand. Effective medications are always more sought after. Driven by PPMA (Pakistan pharmaceutical manufacturer association), Pakistan’s pharmaceutical sector plays an essential part in guaranteeing access to good pharmaceuticals. Thanks to technological improvement and government
Explore the Global Landscape of Pharmaceutical Production Read More »
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
